← All trials
NCT05144100
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2021
- Primary completion
- Jun 30, 2029
- Completion date
- Jun 30, 2031
- First posted
- Dec 3, 2021
- Last posted
- Dec 3, 2021
- Enrollment
- 498
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tata Memorial HospitalLead sponsor
- Tata Memorial HospitalReponsible party - principal investigator
- All India Institute of Medical SciencesCollaborator
- Amrita Institute of Medical SciencesCollaborator
- Tata Memorial HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.